- ►iovs.org R Tzekov, T Lin, KM Zhang, B Jackson, A … - Investigative ophthalmology & visual science, 2006 - ARVO RESULTS. Various morphologic changes, including whitening of the treated area,
RPE proliferation, closure of the choroidal vasculature, and subretinal edema
(followed by foveolar thinning) were observed. Most of the changes ... Cited by 31 - Related articles - BL Direct - All 4 versions
S Michels, J Wachtlin, MA Gamulescu, H … - Ophthalmology, 2005 - Elsevier To compare the efficacy and safety of early retreatment with verteporfin therapy
with that of approved standard verteporfin therapy in neovascular age-related
macular degeneration. ... Two hundred three patients with predominantly ... Cited by 13 - Related articles - All 15 versions
T Moutray, M Alarbi, G Mahon, M Stevenson, … - British Journal of Ophthalmology, 2008 - bjo.bmj.com Results: 74 patients were included in this study. Correlations were highly
statistically significant for both NVA and contrast sensitivity with GLD, CNV
area and leakage (p<0.01 for all combinations). With DVA, modest ... Cited by 13 - Related articles - BL Direct - All 4 versions
KKM FRANZCO, AR FRCOphth, JW BMBC, … - Clinical & Experimental Ophthalmology - interscience.wiley.com Methods: A retrospective review of 172 eyes of 172 consecutive patients who
received photodynamic therapy for predominantly classic with and without occult,
minimally classic and occult choroidal neovascular membranes secondary to ... Cited by 5 - Related articles - BL Direct - All 3 versions
- ►duanessolution.com F Parmeggiani, C Costagliola, D Gemmati, S D' … - Pharmacogenetics and Genomics, 2007 - journals.lww.com Page 1. Original article 1039 Predictive role of coagulation-balance gene polymorphisms
in the efficacy of photodynamic therapy with verteporfin ... Cited by 3 - Related articles - BL Direct - All 8 versions
K Yamashiro, A Tsujikawa, A Nishida, Y … - Japanese Journal of Ophthalmology, 2007 - Springer Although PCV tends to have a better prognosis than AMD, PCV also results in
severe loss of visual function. Pho- todynamic therapy (PDT) with verteporfin is
one of the treatment options for eyes with subfoveal choroidal neovas- ... Cited by 2 - Related articles - All 2 versions
AM Mackay, MC Brown, I Grierson, SP … - Documenta Ophthalmologica, 2008 - Springer Abstract Purpose To investigate the role of multifocal elec- troretinography
(mfERG) in predicting the outcome of photodynamic therapy (PDT) for neovascular
age- related macular degeneration (AMD). Methods Participants underwent ... Cited by 2 - Related articles - BL Direct - All 3 versions
AF Cruess, G Zlateva, AM Pleil, B Wirostko - Acta Ophthalmologica, 2009 - interscience.wiley.com Photodynamic therapy (PDT) with verteporfin has been used less comprehensively
in the treatment of exudative age-related macular degeneration (AMD), and
specifically of choroidal neovascularization (CNV), since the advent of ... Cited by 3 - Related articles - All 3 versions
MD Lucroy - Seminars in Avian and Exotic Pet Medicine, 2005 - Elsevier Photodynamic therapy (PDT) is a novel form of treatment for solid cancers. It
relies on the systemic administration of a light-reactive drug (photosensitizer)
to the patient. Through various mechanisms, the photosensitizer localizes ... Cited by 1 - Related articles - All 2 versions
